In oncology, the success of treatment against a specific cancer is linked to the ability to detect tumor cells as early as possible: early diagnostics are essential part in the fight against cancer. In that respect, there is a need for sensitive methods to find traces of cancer biomarkers in samples coming from patients. A vision for the future of cancer diagnostics would be based on the analysis of bodily fluids to find these biomarkers. A high sensitivity is there a strong pre-requisite to be able to distinguish genetic alterations at the level of traces in such samples.
展开▼
